FDA warns of fetal risk of two transplant drugs

Category: Health

Publish Date: 05-16-2008 01:46 PM -0700

WASHINGTON (Reuters) - U.S. health officials issued an alert on Friday about the risk of first-trimester miscarriages and birth defects from Novartis AG and Roche Holding AG transplant drugs.

Continue to Original Story >